Siberia | Technology & innovation

Cancer testing to be eased by protein bioluminescence

7 Oct '22
Russian scientists at the Krasnoyarsk Research Center and the Siberian Federal University have developed new artificial hybrid proteins that are capable of rapidly pinpointing oncology markers in a patients blood.

If cancer is identified, the proteins are said to be able to proactively send out a bioluminescent signal a physician could use to diagnose the case.

Experiments reportedly revealed that the proteins were stable and active enough, and also impervious to negative temperatures.

The new project is expected to lay the foundation for the development of high-accuracy test systems for cancer diagnostics.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations: Krasnoyarsk

Tags: cancer (72) / diagnostics (31) / bioluminescent signal (0) / artificial hybrid proteins (0) /

Latest News: Siberia
22 Nov '22 | Technology & innovation
9 Nov '22 | Telecoms, media | Technology & innovation
1 Nov '22 | Technology & innovation | Materials, extraction
27 Oct '22 | Energy, utilities | Technology & innovation
13 Oct '22 | Retail, FMCG | Technology & innovation
 

Feature stories

8 Nov '22
Cerebral vascular disorders are responsible for a...
5 Sep '22
Scientists at the Moscow Lomonosov State University...
21 Jul '22
Researchers in Perm, in the West Urals, are reported...
Search (News archive - 22997)
Technology Scouting Solutions For Industry
NATT
Advertising
Marchmont News

Latest News

2 Dec '22
Russian scientists have developed new polymer-based...
1 Dec '22
Scientists in the Urals region experimented with...
30 Nov '22
A new method of conducting radiotherapy without...

Most read stories from last week

1 Dec '22
Scientists in the Urals region experimented with...
2 Dec '22
Russian scientists have developed new polymer-based...
30 Nov '22
A new method of conducting radiotherapy without...